Faculty Opinions recommendation of Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial.

2016 ◽  
Author(s):  
Vivek Kumbhari
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Class Ii ◽  
Class Iii ◽  
Percutaneous Gastrostomy ◽  
Randomized Controlled ◽  
Class Iii Obesity

scholarly journals Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

2017 ◽  
Vol 112 (3) ◽  
pp. 447-457 ◽  
Author(s):  
Christopher C Thompson ◽  
Barham K Abu Dayyeh ◽  
Robert Kushner ◽  
Shelby Sullivan ◽  
Alan B Schorr ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Class Ii ◽  
Class Iii ◽  
Percutaneous Gastrostomy ◽  
Randomized Controlled ◽  
Class Iii Obesity

scholarly journals 1190: Suture vs. staples for cesarean skin closure in class III obesity: A randomized controlled trial

2020 ◽  
Vol 222 (1) ◽  
pp. S732-S733
Author(s):  
Rachel L. Rodel ◽  
Trevor Quiner ◽  
Kendra M. Gray ◽  
Ana Bodea Braescu ◽  
Richard Gerkin ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Skin Closure ◽  
Class Iii ◽  
Randomized Controlled ◽  
Class Iii Obesity

scholarly journals Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial

Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Aldo Ferreira-Hermosillo ◽  
Mario Antonio Molina-Ayala ◽  
Diana Molina-Guerrero ◽  
Ana Pamela Garrido-Mendoza ◽  
Claudia Ramírez-Rentería ◽  
...  
Keyword(s):  
Weight Loss ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Class Iii ◽  
Randomized Controlled ◽  
Metformin Monotherapy ◽  
Class Iii Obesity

Early headgear activator treatment of Class II malocclusion with excessive overjet: a randomized controlled trial

2020 ◽  
Author(s):  
Jenny Kallunki ◽  
Lars Bondemark ◽  
Liselotte Paulsson
Keyword(s):  
Randomized Controlled Trial ◽  
Early Treatment ◽  
Untreated Control ◽  
Controlled Trial ◽  
Class Ii ◽  
Control Group ◽  
Class Ii Malocclusion ◽  
Single Centre ◽  
Intention To Treat ◽  
Randomized Controlled

Summary Objectives To compare early headgear activator treatment of Class II malocclusion with excessive overjet with untreated control subjects in terms of the primary outcomes overjet and overbite as well as the effect regarding oral-health-related quality of life (OHRQoL), lip closure, incidence of trauma, and skeletal changes. Trial design Two-arm parallel group single-centre randomized controlled trial. Material and methods A total of 60 children (mean age 9.5 years) presenting a Class II malocclusion with excessive overjet were recruited. The trial was designed as intention-to-treat and the participants randomized by an independent person not involved in the trial to either early treatment with headgear activator or to an untreated control group (UG). Dental and skeletal variables as well as registrations of OHRQoL, lip closure, and incidence of trauma were recorded. For the treatment group, data were registered at baseline before treatment and when treatment was finished, corresponding to approximately 2 years. For the UG, registrations were made at baseline and at 11 years of age. Observers were blinded to treatment allocation when assessing outcomes. Results Early treatment with headgear activator significantly decreased overjet and improved molar relationship when compared with untreated controls. The effects were primarily due to dentoalveolar changes. Early treatment had no evident effect regarding OHRQoL, lip closure, or incidence of trauma. Lack of cooperation resulted in unsuccessful treatments for 27% of the patients. Limitations The trial was a single-centre trial and can thus be less generalizable. Conclusions The main treatment effect of early headgear activator treatment of Class II malocclusion with excessive overjet is reduction of overjet. Trial registration NCT04508322.

scholarly journals Comparison of effects of cervical headgear treatment on skeletal facial changes when the treatment time is altered: a randomized controlled trial

2019 ◽  
Vol 41 (6) ◽  
pp. 631-640
Author(s):  
Johanna Julku ◽  
Kirsi Pirilä-Parkkinen ◽  
Mimmi Tolvanen ◽  
Pertti Pirttiniemi
Keyword(s):  
Randomized Controlled Trial ◽  
Treatment Group ◽  
Controlled Trial ◽  
Class Ii ◽  
Class Ii Malocclusion ◽  
Gonial Angle ◽  
Randomized Controlled ◽  
Face Height ◽  
Upper Face ◽  
Facial Changes

Summary Background There is a lack of evidence based on longitudinal information in the field of Class II malocclusion management with cervical headgear (CH), especially in a randomized setting. Objectives The main objective of this study was to evaluate skeletal facial changes, particularly in vertical dimensions, after Kloehn-type CH treatment in children when the timing of treatment is altered. Trial design Prospective, parallel-group, randomized controlled trial. Methods Screened children with Class II malocclusion were randomized in 1:1 ratio to two groups of equal size by sealed-envelope randomization: the early group (EG), where active CH treatment was started at the age of 7.8 years, and the late group (LG), where CH treatment was started at the age of 9.5 years. The active treatment was continued until normal Class I occlusion on first molars was achieved. Cephalograms were taken at three different time points. Changes in cephalometric measurements were compared between groups and genders. Blinding was applicable for outcome evaluation. Results Of 67 randomized children, 56 completed the study. Upper face height increased during the CH treatment phase, as the parameter N–ANS increased significantly during the active treatments of EG (P < 0.05) and LG (P < 0.05). Also, the parameter NSL–PL increased significantly during the treatment of EG (P < 0.01) and during the treatment of LG (P < 0.01). The Gonial angle decreased significantly in the early CH treatment group compared to the later treatment group (T0–T2: P < 0.01). CH improved the antero-posterior jaw relationship. No harms were encountered. Conclusions Although the upper face height increased, the mandible showed anterior rotation after CH treatment. The Gonial angle was significantly decreased in the EG compared to the LG. There were gender-specific differences in both sagittal and vertical dimensions when examining interrelations in dimensional changes. The differences found between the early and later treatment groups were not clinically important when the cephalometric results are considered. Clinical registration ClinicalTrials.gov (NCT02010346).

Temporomandibular disorders after early class II treatment with bionators and headgears : results from a randomized controlled trial

1995 ◽  
Vol 1 (3) ◽  
pp. 149-164 ◽  
Author(s):  
Stephen D. Keeling ◽  
Cynthia W. Garvan ◽  
Gregory J. King ◽  
Timothy T. Wheeler ◽  
Susan McGorray
Keyword(s):  
Randomized Controlled Trial ◽  
Temporomandibular Disorders ◽  
Controlled Trial ◽  
Class Ii ◽  
Class Ii Treatment ◽  
Randomized Controlled

Is early class III protraction facemask treatment effective? A multicentre, randomized, controlled trial: 3-year follow-up

2012 ◽  
Vol 39 (3) ◽  
pp. 176-185 ◽  
Author(s):  
Nicky Anne Mandall ◽  
Richard Cousley ◽  
Andrew DiBiase ◽  
Fiona Dyer ◽  
Simon Littlewood ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Class Iii ◽  
Randomized Controlled

scholarly journals Use of direct miniplate anchorage in conjugation with Forsus Fatigue Resistant device in class II growing females: a randomized controlled trial

2018 ◽  
Vol 54 (12) ◽  
pp. 19-38
Author(s):  
Sherif ElKordy ◽  
Amr Aboulezz ◽  
Mona Fayed ◽  
Mai Aboulfotouh ◽  
Yehya Mostafa
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Class Ii ◽  
Randomized Controlled ◽  
Forsus Fatigue Resistant Device
Sign in / Sign up

Export Citation Format

Share Document